Zhujiang Hospital of Southern Medical University — Guangzhou, Guangdong

Public research footprint of Zhujiang Hospital of Southern Medical University, compiled from the ClinicalTrials.gov public registry.

231

Registered studies

116

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Glypican-3 (GPC3)-Positive Squamous Non-small Cell Lung Cancer · Chronic Lymphocytic Leukemia · Relapsed/Refractory Diffuse Large B-Cell Lymphoma · Small Lymphocytic Lymphoma

Recently updated registry entries

NCT06012240 — A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and… (Recruiting)
NCT06679140 — A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent… (Recruiting)
NCT06717347 — A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Zhujiang Hospital of Southern Medical University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.